Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study
- PMID: 16849747
- DOI: 10.1200/JCO.2006.05.6341
Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study
Abstract
Purpose: Mediastinal restaging after induction therapy for non-small-cell lung cancer remains a difficult and controversial issue. The goal of this prospective study was to compare the performance of integrated positron emission tomography (PET)--computed tomography (CT) and remediastinoscopy in the evaluation of mediastinal lymph node metastasis after induction chemotherapy.
Patients and methods: Thirty consecutive stage IIIA-N2 non-small-cell lung cancer patients surgically treated at our institution were entered onto this prospective study. N2 disease was proven by cervical mediastinoscopy, at which a mean number of 3.8 lymph node levels were biopsied. After completion of induction chemotherapy, the mediastinum was reassessed by integrated PET-CT and remediastinoscopy. All patients underwent thoracotomy with attempted complete resection and systematic nodal dissection.
Results: PET-CT showed no evidence of nodal disease (N0) in 13 patients, Hilar nodal disease (N1) disease in three patients, and residual mediastinal disease (N2) in 14 patients. Remediastinoscopy was positive in only five patients. The preinduction involved lymph node level could be accurately re-evaluated in 18 patients. This was not the case in the other 12 because of extensive fibrosis and adhesions. In 17 patients, persistent N2 disease was found at thoracotomy. The sensitivity, specificity, and accuracy of PET-CT were 77%, 92%, and 83%, respectively. These parameters for remediastinoscopy were 29%, 100%, and 60%, respectively. Sensitivity (P < .0001) and accuracy (P = .012) were significantly better for PET-CT.
Conclusion: After a thorough staging mediastinoscopy, postinduction remediastinoscopy had a disappointing sensitivity because of adhesions and fibrosis. Integrated PET-CT yielded a better result than that obtained in previous studies with side-by-side PET and CT images.
Comment in
-
Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer.J Clin Oncol. 2006 Jul 20;24(21):3317-8. doi: 10.1200/JCO.2006.06.5235. J Clin Oncol. 2006. PMID: 16849743 No abstract available.
-
Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement, or surgical technique?J Clin Oncol. 2006 Nov 20;24(33):5338; author reply 5339-40. doi: 10.1200/JCO.2006.08.7577. J Clin Oncol. 2006. PMID: 17114674 No abstract available.
Similar articles
-
Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?Thorac Cardiovasc Surg. 2012 Mar;60(2):116-21. doi: 10.1055/s-0030-1271148. Epub 2011 Jun 20. Thorac Cardiovasc Surg. 2012. PMID: 21692019
-
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.Clin Nucl Med. 2007 Aug;32(8):607-12. doi: 10.1097/RLU.0b013e3180a1ac87. Clin Nucl Med. 2007. PMID: 17667432 Clinical Trial.
-
Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. doi: 10.1016/j.jtcvs.2007.09.029. Epub 2008 Jan 11. J Thorac Cardiovasc Surg. 2008. PMID: 18329480
-
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review.
-
Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.Swiss Med Wkly. 2011 Mar 8;141:w13168. doi: 10.4414/smw.2011.13168. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21384283 Review.
Cited by
-
Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment.Thorac Surg Sci. 2011;8:Doc01. doi: 10.3205/tss000021. Epub 2011 Dec 27. Thorac Surg Sci. 2011. PMID: 22205919 Free PMC article.
-
Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.Eur Radiol. 2012 Mar;22(3):588-606. doi: 10.1007/s00330-011-2299-8. Epub 2011 Oct 4. Eur Radiol. 2012. PMID: 21969110 Review.
-
Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.J Thorac Cardiovasc Surg. 2016 Apr;151(4):969-77, 979.e1-3. doi: 10.1016/j.jtcvs.2015.09.127. Epub 2015 Oct 19. J Thorac Cardiovasc Surg. 2016. PMID: 26614420 Free PMC article.
-
Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.Nat Rev Clin Oncol. 2009 May;6(5):278-86. doi: 10.1038/nrclinonc.2009.39. Nat Rev Clin Oncol. 2009. PMID: 19390554 Free PMC article. Review.
-
Are the metabolic evaluation criteria sufficient for FDG PET/CT after chemo-radiotherapy in non-small cell lung cancer?J Thorac Dis. 2019 May;11(Suppl 9):S1263-S1266. doi: 10.21037/jtd.2019.02.49. J Thorac Dis. 2019. PMID: 31245104 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical